Literature DB >> 206308

The neuronal origin of prostaglandin released from the rabbit portal vein in response to electrical stimulation.

R Greenberg.   

Abstract

Transmural electrical stimulation of the isolated portal vein of the rabbit was accompanied by the release of a prostaglandin-like substance (PLS). Thin layer chromatography coupled with bioassay indicated that this substance was probably prostaglandin E2 (PGE2). 2 Indomethacin potentiated the response of the portal vein to electrical stimulation at 2 Hz and abolished the release of the PLS. 3 There was no significant change in the amount of PLS released from the portal vein in response to electrical stimulation at 2 Hz when the contractile response of the portal vein was prevented by pretreatment with phentolamine or guanthidine. 4 In vitro denervation of the portal vein with 6-hydroxydopamine or the omission of Ca2+ from the bathing solution caused a significant reduction in the amount of PLS released from the portal vein in response to electrical stimulation at 2 hertz. 5 It is concluded that electrical stimulation of the isolated portal vein of the rabbit is accompanied by the release of a PLS, probably PGE2, from a neuronal source. The synthesis and release of the PLS is Ca2+ -dependent.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206308      PMCID: PMC1668283          DOI: 10.1111/j.1476-5381.1978.tb07777.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  16 in total

Review 1.  Basic mechanisms of prostaglandin action on autonomic neurotransmission.

Authors:  P Hedqvist
Journal:  Annu Rev Pharmacol Toxicol       Date:  1977       Impact factor: 13.820

2.  Release of renal prostaglandin by catecholamines: relationship to renal endocrine function.

Authors:  P Needleman; J R Douglas; B Jakschik; P B Stoecklein; E M Johnson
Journal:  J Pharmacol Exp Ther       Date:  1974-02       Impact factor: 4.030

3.  Prostaglandin controls neuromuscular transmission in guinea-pig vas deferens.

Authors:  P Hedqvist; U S von Euler
Journal:  Nat New Biol       Date:  1972-03-29

4.  Facilitation of sympathetic neurotransmission in the cat spleen after inhibition of prostaglandin synthesis.

Authors:  P Hedqvist; L Stjärne; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1971-11

5.  Increased nerve stimulation induced release of noradrenaline from the rabbit heart after inhibition of prostaglandin synthesis.

Authors:  B Samuelsson; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1971-10

6.  The release of prostaglandins from lung and other tissues.

Authors:  P Piper; J Vane
Journal:  Ann N Y Acad Sci       Date:  1971-04-30       Impact factor: 5.691

7.  Augmented noradrenaline release following nerve stimulation after inhibition of prostaglandin synthesis with indomethacin.

Authors:  P H Chanh; M Junstad; A Wennmalm
Journal:  Acta Physiol Scand       Date:  1972-12

8.  In vitro denervation of the portal vein and caudal artery of the rat.

Authors:  O Aprigliano; K Hermsmeyer
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

9.  Adrenergic neuronal degeneration induced in portal vein and caudal artery by 6-hydroxydopamine in vitro.

Authors:  O Aprigliano; K E Rybarczyk; K Hermsmeyer; L S Van Orden
Journal:  J Pharmacol Exp Ther       Date:  1976-09       Impact factor: 4.030

10.  Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1972-03       Impact factor: 8.739

View more
  2 in total

1.  Prostaglandin-induced inhibition of acetylcholine release from neuronal elements of dog tracheal tissue.

Authors:  T Inoue; Y Ito; K Takeda
Journal:  J Physiol       Date:  1984-04       Impact factor: 5.182

2.  A possible negative feedback control of excitatory transmission via prostaglandins in canine small intestine.

Authors:  N Nakahata; H Nakanishi; T Suzuki
Journal:  Br J Pharmacol       Date:  1980-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.